Learning Objectives:

1. Review the burden of the disease - screening recommendations for osteoporosis from endocrine and primary care perspectives
2. Expanding treatment beyond the bisphosphonates -provide an update on newer osteoanabolic pharmacotherapies for osteoporosis; Bone loss and vertebral fractures after denosumab discontinuation - are there strategies to prevent this?
3. Provide an Update on Clinical Bone Trials at University of Chicago - PATH Forward, ATOM, WearABLe trials